ADAMA Agricultural Solutions Q3 & 9M 2025 FINANCIAL SUMMARY Legal Notice This presentation is for marketing and information purposes only. By this presentation, neither ADAMA Ltd. nor ADAMA Agricultural Solutions Ltd. (together the "Company" or "ADAMA") intend to give, and the presentation does not constitute, professional or business advice or an offer or recommendation to perform any transaction in the Company's securities. The accuracy, completeness and/or adequacy of the content of this presentation, as ...

Financial Data and Key Metrics Changes - Organic sales increased by 11% year-over-year in Q3, with both seed and crop protection contributing to this growth [20] - Year-to-date organic sales were up 6%, driven by a 3% increase in price mix and a 4% increase in volume for seeds [21] - Operating EBITDA for the quarter was positive, showing over 600 basis points of margin expansion compared to the previous year [20] - Full-year operating EBITDA is now expected to be in the range of $3.8 billion to $3.9 billion, reflecting a 14% growth at the midpoint [13][24] Business Line Data and Key Metrics Changes - The seed business achieved $200 million in productivity and deflation benefits, alongside $90 million in royalty improvements [9] - Crop protection business is expected to see full-year EBITDA growth in the high single digits, driven by demand for differentiated technology [10] - New products and biologicals in crop protection delivered double-digit volume gains compared to the prior year [21] Market Data and Key Metrics Changes - The overall agricultural market fundamentals remain mixed, with record demand for food and fuel, and major crop inventories within normal ranges [12] - In Brazil, the crop protection market is expected to stabilize pricing, moving from high single-digit losses to mid-single-digit growth [60] - The crop protection industry is anticipated to see low single-digit growth in 2026, with high single-digit growth in biologicals [16] Company Strategy and Development Direction - The company plans to separate into two public entities by the second half of 2026 to better position its seed and crop protection businesses for long-term growth [6][8] - Focus on differentiated technologies and collaborations is expected to drive innovation and market success [7] - The introduction of hundreds of new products is anticipated to enhance returns for farmers and contribute to volume growth [17] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the future, citing strong early demand for safrinha seeds in Brazil and a robust R&D pipeline valued at $9 billion [8][30] - The company is raising its full-year operating EBITDA guidance due to broad-based organic sales growth and cost improvements [24] - Management noted that the agricultural market is experiencing competitive pricing dynamics, particularly in Brazil, but underlying demand remains strong [12][60] Other Important Information - The company expects to achieve a free cash flow conversion rate of approximately 50% for the year, alongside $1 billion in share repurchases [15][26] - The anticipated separation is aimed at sharpening focus and accelerating innovation, with a commitment to delivering strong results during the transition [18] Q&A Session Summary Question: What should the independent company focus on post-separation? - Management highlighted the importance of their strong R&D pipeline and differentiated technology as key areas for growth and margin improvement [30] Question: Will there be further pruning of the AI portfolio? - Management expressed satisfaction with the current portfolio and indicated openness to partnerships and collaborations to enhance offerings [36] Question: How are credit market conditions evolving for growers in Latin America? - Management noted that while there are higher borrowing costs and increased bankruptcies, Corteva is managing risks effectively with minimal losses [40][41] Question: What are the expectations for biologicals growth? - Management reported strong growth in biologicals, with expectations for continued high single- to low double-digit growth rates in the future [53] Question: How is the company managing working capital? - Management indicated that working capital improvements have contributed significantly to free cash flow, with expectations for typical inventory builds in Q4 [73]

Financial Data and Key Metrics Changes - Organic sales increased by 11% year-over-year for the third quarter, with both seed and crop protection contributing to this growth [20] - Year-to-date organic sales were up 6%, driven by a 3% increase in seed price mix and a 4% increase in volume [21] - Operating EBITDA for the third quarter showed a significant improvement, with a margin expansion of over 600 basis points compared to the prior year [20][21] - Full year operating EBITDA is now expected to be in the range of $3.8 billion to $3.9 billion, reflecting a 14% growth at the midpoint [13][24] Business Line Data and Key Metrics Changes - The seed business achieved $200 million in productivity and deflation benefits, alongside $90 million in royalty improvements [9] - Crop protection business is expected to see full year EBITDA growth in the high single digits, driven by demand for differentiated technology [10] - New products and biologicals in crop protection delivered double-digit volume gains compared to the prior year [21] Market Data and Key Metrics Changes - The overall agricultural market fundamentals remain mixed, with record demand for food and fuel, and major crop inventories within normal ranges [12] - In the crop protection market, competitive pricing dynamics persist in some major markets, but underlying farmer demand remains strong [12] - Brazil is expected to see mid-single-digit pricing improvements in crop protection, compared to high single-digit losses the previous year [60] Company Strategy and Development Direction - The company plans to separate into two public entities to better position its seed and crop protection businesses for long-term growth [6][8] - The focus will be on leveraging new technologies like gene editing and artificial intelligence to capture market opportunities [7] - The company aims to maintain a strong R&D investment of 6%-7% of revenue to drive innovation [33] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the future, citing strong current performance and the potential for greater success as separate entities [8] - The company anticipates continued record demand for grains and oilseeds, with farmers prioritizing top-tier technologies [15] - The crop protection industry is expected to see low single-digit growth in 2026, with high single-digit growth in biologicals [16] Other Important Information - The company is on track for $1 billion in share repurchases in 2025, reflecting confidence in its balance sheet and cash flow outlook [26] - Free cash flow is expected to be approximately $1.9 billion, with a cash conversion rate of about 50% [24] Q&A Session Summary Question: What should the independent company focus on post-separation? - Management highlighted the importance of their R&D pipeline and differentiated technology as key growth drivers for the independent crop protection business [30] Question: Will there be further pruning of the AI portfolio? - Management expressed satisfaction with the current portfolio and indicated openness to partnerships for further innovation [36] Question: How are credit market conditions evolving for growers in Latin America? - Management noted that while there are higher borrowing costs and increased bankruptcies, Corteva is managing risks effectively with minimal losses [40] Question: What are the expectations for biologicals growth? - Management is pleased with the current growth in biologicals and expects continued strong growth rates in the future [53] Question: How is the company managing working capital? - Management indicated that working capital improvements have been a significant driver of free cash flow, with expectations for typical inventory builds in Q4 [73]

Financial Data and Key Metrics Changes - Organic sales increased by 11% year-over-year for the third quarter, with both seed and crop protection contributing to this growth [17] - Year-to-date organic sales were up 6%, driven by a 3% increase in seed price mix and a 4% increase in seed volume [18] - Operating EBITDA for the third quarter showed a significant improvement, with a margin expansion of over 600 basis points compared to the prior year [17] - Full year operating EBITDA is now expected to be in the range of $3.8 billion to $3.9 billion, reflecting a 14% growth at the midpoint compared to the previous year [10][21] Business Line Data and Key Metrics Changes - The seed business achieved $200 million in productivity and deflation benefits, alongside $90 million in royalty improvements [7] - Crop protection business is expected to see full year EBITDA growth in the high single digits, driven by demand for differentiated technology [8] - New products and biologicals in crop protection delivered double-digit volume gains compared to the prior year [18] Market Data and Key Metrics Changes - The overall agricultural market fundamentals remain mixed, with record demand for food and fuel, and major crop inventories within normal ranges [10] - Competitive pricing dynamics continue in some major markets, particularly in crop protection [10][15] - In Brazil, crop protection pricing is expected to stabilize, moving from high single-digit losses last year to mid-single-digit losses this year [41] Company Strategy and Development Direction - The company announced plans to separate into two public companies to better position its seed and crop protection businesses for long-term growth [4][6] - Focus on differentiated technologies and new product introductions is expected to drive solid returns for farmers and premium market positioning [15] - The company anticipates rolling out several hundred new hybrids and varieties in 2026 to enhance farmer productivity [8] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the future, citing strong early safrinha seed demand in Brazil and a robust R&D pipeline valued at $9 billion [6][25] - The company expects low single-digit growth in the crop protection industry, with high single-digit growth in biologicals [14] - Management highlighted the importance of maintaining a strong balance sheet and cash flow outlook, with a commitment to $1 billion in share repurchases [23] Other Important Information - The company is on track for a free cash flow conversion rate of approximately 50% for the year [12] - The anticipated separation is expected to unlock value and sharpen focus on innovation [16] - The company is committed to maintaining R&D investment at 6%-7% of revenue to support ongoing innovation [28] Q&A Session Summary Question: What should the independent company focus on post-separation? - Management emphasized the strength of the crop protection business and the depth of its R&D pipeline, indicating that the focus should remain on differentiated technology and collaboration opportunities [24][25] Question: Are there plans for further pruning of the AI portfolio? - Management expressed satisfaction with the current portfolio and indicated openness to partnerships and collaborations to enhance offerings [29][30] Question: How are credit market conditions evolving for growers in Latin America? - Management noted that while there are higher borrowing costs and increased bankruptcies, Corteva has managed risks effectively, resulting in minimal losses [31][32] Question: What are the expectations for synergy costs post-separation? - Initial estimates for synergy costs were projected at $80 million to $100 million, with ongoing efforts to minimize this number [34][36] Question: How is the biologicals segment performing? - Management reported strong growth in biologicals, with expectations for continued high single-digit to low double-digit growth rates [39] Question: What is the outlook for crop chemical pricing? - Management expects crop chemical pricing to stabilize, with Brazil showing signs of improvement compared to previous years [41][42] Question: How is the seed market share performing? - Management expressed confidence in gaining market share in key crops, particularly corn and soy, with expectations for Conkesta to reach double-digit market penetration in Brazil [50][51]

Group 1: Export Performance - The total export quantity under item 3808 increased by 20.91% year-on-year from January to September 2025, with a significant increase of 28.69% in the third quarter [3] - The total export value under item 3808 increased by 16.48% year-on-year from January to September 2025, with a notable increase of 21.61% in the third quarter [4] - The average export price rose from USD 2.87/Kg in January to USD 2.96/Kg in September 2025, showing stability [4] Group 2: Company Strategy and Growth - The company's TO C business revenue share increased from 37.73% in the first nine months of 2024 to 41.39% in the reporting period [6] - The revenue share from the EU and North America increased from 8.53% in the first nine months of 2024 to 11.35% in the reporting period [6] - The revenue share from insecticides and fungicides increased from 25.46% to 28.64% during the same period [6] Group 3: Market Challenges - The company faced delays in the planting and procurement seasons in Brazil and Argentina, impacting sales [9] - Credit risk in Brazil and Argentina has risen, leading to the cancellation of contracts worth approximately USD 40 million in the third quarter [9] - The company has identified accounts receivable risk as a top operational risk in its 2025-2029 strategic plan [9] Group 4: Financial Outlook - The company aims for a gradual increase in gross margin and net margin from 2025 to 2029, with specific numerical targets set [14] - The gross margin is expected to rise due to the increasing share of TO C business, which has a gross margin approximately 15 percentage points higher than TO B business [14] - The company anticipates that the gross margin will benefit from the successful expansion of biological agents, which currently have the highest gross margin among product categories [15] Group 5: Competitive Landscape - The separation of seed and crop protection businesses by multinational companies like Corteva is expected to benefit non-patented crop protection companies by reducing customer loyalty to bundled products [10] - The company has not yet included seed business in its strategic planning, focusing instead on becoming a leading crop protection company [11] Group 6: Future Projections - The company expects steady growth in revenue and net profit in 2026, primarily driven by markets in Brazil, Argentina, the EU, North America, Africa, and Australia/New Zealand [18] - The company aims to achieve a 10% global market share in the crop protection market, which is valued at approximately USD 75 billion [22]

Financial Performance - Q2 2025 - Sales increased by 3% to $968 million compared to Q2 2024[11] - Gross profit increased by 14% compared to Q2 2024[11] - EBITDA increased by 19.3% compared to Q2 2024[10] - Net loss improved by $47 million, from -$54 million to -$8 million[12] Financial Performance - H1 2025 - Sales decreased by 2.2% to $1,845 million compared to H1 2024[14] - Gross profit increased by 8.2% compared to H1 2024[14] - EBITDA increased by 19.9% compared to H1 2024[10] - Net profit was $22 million, compared to a loss of $69 million in H1 2024[14] - Free cash flow increased by $24 million to $32 million compared to $8 million in H1 2024[10] Regional Performance - North America sales increased by 25% in Q2 and 20% in H1 at CER[17, 17] - Latin America sales increased by 6% in Q2 but decreased by 4% in H1 at CER[18, 18] - Asia Pacific sales decreased by 14% in both Q2 and H1 at CER[20, 20]

Financial Data and Key Metrics Changes - Total revenues for 2025 were approximately $3.2 million, an increase from $2.3 million in 2024, primarily driven by strong seed sales from the subsidiary Castera [9][26] - Research and development expenses for 2025 were approximately $4.8 million, down from $6.5 million in the same period last year, due to reduced R&D activities at Biomica and the discontinuation of operations at Canonic [10][27] - Total operating expenses for 2025 were approximately $7.7 million, significantly decreased from $11.1 million in the same period last year, attributed to reduced activity levels in subsidiaries [11][29] - The net loss for 2025 was approximately $7.7 million, compared to $9.8 million in the same period last year, reflecting decreased operating expenses and increased financing income [32] Business Line Data and Key Metrics Changes - Castera, the subsidiary responsible for seed sales, was the primary contributor to revenue growth, with revenues recognized for seed sales in 2025 [9][26] - Biomica is focused on completing its clinical trial expected in early 2026 and securing partners for its development programs, holding approximately $4 million in cash [17][21] - Laviv Bio's activities were largely sold to ICL, with a total consideration of $15.25 million, enhancing cash flow for Evogene [14] Market Data and Key Metrics Changes - The company is undergoing a strategic shift to maximize the value of Campus AI, focusing on AI-driven discovery and optimization in pharmaceuticals and agriculture [12][19] - The collaboration with Tel Aviv University aims to develop small molecule therapeutics targeting diseases caused by metabolite accumulation, leveraging Campus AI [13] Company Strategy and Development Direction - The strategic priorities include strengthening Campus AI, expanding collaborations in small molecule drug discovery, and streamlining operational expenses [12][19] - The company plans to establish a dedicated business development arm to accelerate growth in the pharmaceutical vertical and maintain strategic collaborations in agriculture [20] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the new strategic direction and the potential for increased investor interest as new collaborations are announced [40] - The company expects continued reductions in operating expenses in the third and fourth quarters of 2025 [42] Other Important Information - Evogene raised $4.4 million through an at-the-market facility, enhancing its financial position and providing an operational runway of approximately 18 months [18] - The company is focusing on operational discipline and long-term value creation, with plans to present its updated corporate strategy at industry conferences [23] Q&A Session Summary Question: How much caster seed inventory do you have today, both finished and expected to be finished after the harvest? - The company has a few hundred tons of castor seed ready for sale and plans to utilize its seeds for cultivation to sell grain to partners [35][36] Question: What steps need to occur before you can announce a castor oil business? - The company is currently focused on grain cultivation and selling grain to partners, with existing crushing oil factories eager for castor grain [38] Question: The stock is still low. When will it start going up? - Management indicated that they cannot control the stock market but are finalizing a new company presentation and plan to announce new collaborations that could positively impact stock value [39][40] Question: How representative are operating expenses in Q2 2025 for going forward operations? - Management confirmed that all cost reductions are fully reflected in the numbers, with expectations for continued expense declines [42] Question: What was revenue in Q2 2025? How should we think about peak sales given recent results? - The revenue in Q2 2025 was primarily from Castera, with expectations for future sales growth as the company engages with multiple partners [43][44] Question: For Campus AI platform, what catalyst milestones should we expect in the next twelve to eighteen months? - The company anticipates announcements of new collaborations and breakthroughs in technology development as key milestones [46][49]

Financial Data and Key Metrics Changes - Corteva reported top and bottom line growth with over 200 basis points of operating EBITDA margin expansion in Q2 2025 compared to the same period last year [6] - Organic sales increased by 7% year-over-year in Q2, with operating EBITDA growth of 13% and a margin expansion of 215 basis points [17][18] - For the first half of 2025, operating EBITDA was up more than $400 million to just over $3.35 billion, with a margin of nearly 31%, reflecting a 300 basis point increase [20] Business Line Data and Key Metrics Changes - The Seed Business Unit experienced a 32% increase in price and volume gains, contributing to a significant performance in North America [18] - Crop Protection business saw an 8% increase in volume, with double-digit growth in Brazil, despite a 2% decline in pricing due to competitive dynamics [18][19] - The Seed segment achieved a $70 million benefit in net royalties, exceeding expectations for the full year [7] Market Data and Key Metrics Changes - Overall agricultural fundamentals remain mixed, with growing demand for grains and oilseeds, but moderated crop prices and margins [11] - The U.S. is expected to have a record harvest, with corn futures reflecting above-average crop condition ratings [12] - The market is seeing a shift from soybeans to corn, with expectations of increased corn acreage in Brazil and Argentina [26] Company Strategy and Development Direction - Corteva is focused on operational excellence initiatives and has raised its full-year net cost improvement target to $450 million from $400 million [7] - The company remains optimistic about growth in 2026, with a focus on investing in growth platforms and delivering meaningful royalty productivity [14] - The strategy includes enhancing product offerings and leveraging out-licensing opportunities, particularly in corn and soybeans [58] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving double-digit bottom line growth and meaningful margin improvement for the year [10] - The company anticipates low to mid-single-digit pricing headwinds in the Crop Protection segment for the second half of the year [9] - Management highlighted the importance of global production keeping pace with consumption, which is critical for maintaining market stability [13] Other Important Information - Corteva is on track for $1 billion in share repurchases in 2025 and announced a nearly 6% increase in the annual dividend [29] - The company expects a full-year free cash flow of approximately $1.9 billion, with a cash conversion rate of about 50% [22] Q&A Session Summary Question: What factors are influencing the forecast for the back half of the year? - Management acknowledged the tough comparison for Crop Protection and negative pricing in Brazil, while also discussing seed acreage expectations [32][33] Question: Can you elaborate on the free cash flow guidance? - Management indicated that the increase in free cash flow guidance is driven by earnings growth and lower cash taxes due to recent legislation [38][41] Question: What are the expectations for share gains in corn and soy? - Management reported strong performance in both corn and soy, with significant market share gains attributed to product performance and licensing strategies [70] Question: How is the company navigating tariff impacts on the supply chain? - Management stated that the impact of tariffs has been minimal due to proactive strategies in improving supply chain resiliency [88][90] Question: What are the expectations for Crop Protection pricing in the back half? - Management noted that while pricing pressures exist, there are signs of stabilization and potential improvement in the Crop Protection market [82][84]

Financial Data and Key Metrics Changes - Corteva reported top and bottom line growth with over 200 basis points of operating EBITDA margin expansion in Q2 2025 compared to the same period last year [5] - Organic sales increased by 7% year-over-year for the quarter, driven by gains in both seed and crop protection [15] - Operating EBITDA for the quarter grew by 13%, with a margin expansion of 215 basis points compared to the prior year [16] Business Line Data and Key Metrics Changes - The Seed business unit experienced a 32% increase in price and volume gains, contributing significantly to the first half results [16] - Crop Protection saw an 8% increase in volume, with double-digit growth in new products and biologicals [17] - The Seed and Crop Protection units combined delivered over $400 million in productivity and cost benefits, including lower commodity costs and raw material deflation [19] Market Data and Key Metrics Changes - Overall agricultural fundamentals remain mixed, with growing demand for grains and oilseeds, but moderated crop prices and margins [10] - The U.S. is expected to see a record harvest, with corn futures reflecting above-average crop condition ratings [11] - The stocks-to-use ratio for corn is expected to remain below historical averages despite the anticipated large crop [12] Company Strategy and Development Direction - Corteva is focused on investing in growth platforms and delivering top-tier technology to enhance farmer productivity and sustainability [14] - The company raised its full-year operating EBITDA guidance to $3.8 billion, reflecting confidence in continued performance [9] - There is an emphasis on out-licensing opportunities, with a projected $4 billion market potential in corn and soybeans [55] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving double-digit bottom line growth and meaningful margin improvement for the year [9] - The company anticipates low to mid-single-digit pricing headwinds in the Crop Protection segment for the second half of the year [8] - Management remains optimistic about growth in 2026, with expectations for continued strong performance in key markets [13] Other Important Information - Corteva announced a nearly 6% increase in the annual dividend, marking the fifth consecutive annual increase [27] - The company is on track for $1 billion in share repurchases in 2025, reflecting a strong balance sheet and cash flow outlook [27] Q&A Session Summary Question: What factors are influencing the forecast for the back half of the year? - Management acknowledged the tough comparisons in Crop Protection and negative pricing pressures in Brazil, while also highlighting expectations for mid-single-digit acreage increases in Latin America [30][34] Question: Can you elaborate on the free cash flow guidance? - The increase in free cash flow guidance to approximately $1.9 billion is attributed to earnings growth and lower cash taxes from recent legislation [40][41] Question: What are the expectations for share gains in corn and soy? - Management indicated strong performance in both corn and soy, with significant market share gains driven by product performance and licensing opportunities [68][70] Question: How are tariffs affecting the supply chain? - The impact of tariffs has been minimal due to proactive strategies in multisourcing and supply chain management [89] Question: What are the expectations for Crop Protection pricing? - Management expects low single-digit pricing declines in Crop Protection, particularly in Brazil, but sees signs of stabilization and potential improvement in 2026 [82][83]

Core Viewpoint - The company, Andermatt A (000553.SZ), confirmed that its main business focuses on crop protection products and does not involve any antibiotic-related business [2] Company Summary - Andermatt A's primary business is in crop protection products [2] - The company does not engage in the antibiotic sector [2]